News 15.09.2022 Schlieren (Zurich), Switzerland, September 15, 2022 – Kuros Biosciences AG (SIX:KURN) a leader in next generation bone graft technologies, announced today the successful completion of a CHF 6.0 million capital increase through a private placement of 3,750,000 new shares of Kuros with a par value of CHF 0.10 each (the...
Events, Internal events
Event date: 13.10.2022
Date: Thursday, 13th October 2022
Time: 4pm - 6pm CEST
Address: Bio-Technopark Schlieren-Zürich, Auditorium, Wagistrasse 25, CH-8952 Schlieren
Parenteral Drug Product: formulation development, capability, and strategy
Join us for the face-to-face event and meet our experts
Lonza’s Parenteral Drug Product Services has been experiencing fast growth over the last years and today provides fully integrated,...
News 08.09.2022 Zurich-Schlieren, Switzerland, September 08, 2022. Proteomedix, a Swiss diagnostics company committed to advance prostate cancer care, announces grant of patent in China for Proclarix®. The China National Intellectual Property Administration notified Proteomedix of the grant of the patent for the invention described in the application No. 201780043349.5, titled “Method of detecting proteins in...
Events, Internal events
Event date: 21.09.2022
Need for speed – How to accelerate bioprocess development with seamlessly integrated data & machine-learning tools
We invite you to an exciting upcoming webinar about the acceleration of bioprocess development with digital solutions. In our newly formed partnership with DataHow AG, we couple Lucullus® to the DataHowLab, a machine learning-based modeling...
Events, Internal events
Event date: 07.09.2022
Time: 13:45 - 16:45 CET
Location: DiNAQOR AG, Wagistrasse 25, 8952 Schlieren
Pushing the Boundaries in Biomolecular Interaction Analysis with the Creoptix WAVEsystem and waveRAPID - From Biologics to Fragment-Based Drug Discovery.
We’re visiting six locations across the EU and the US to deliver the latest insights into binding kinetics and affinity -...